Partnering Solutions
-
Study Start-Up Shouldn’t Slow Your Trials Down
5/24/2023
Clinical teams are responsible for driving trial timelines during the study start-up phase of any study. Unearth how Florence SiteLink is able to create a digital link between teams and their sites.
-
Multitherapeutic Limitations: Knowing How To Choose The Right Resource
7/20/2021
Chief medical officers looking for outsourcing services on a study are often fed lines from large CROs on how they can provide individuals with multitherapeutic backgrounds.
-
Partnering With Leading Innovator TrakCel To Support CGTs
9/27/2023
Our combined offering aims to increase speed-to-therapy by increasing connectivity between providers and hub patient services.
-
eClinicalGPS
4/10/2018
eClinicalGPS is designed to automate and streamline clinical site payments, getting sites paid faster and more accurately with less administrative burden. Configured
-
Kayentis: 18+ years Of Success Stories With Big Pharma
12/16/2022
Discover how Kayentis' governance structure is made to manage Big Pharma needs and builds long-term relationships.
-
Dual Sourcing: Mitigating Risk In Your Supply Chain
8/22/2022
Dual sourcing should be implemented to reduce risk and ensure an uninterrupted supply of critical, life-saving therapies. Recent FDA draft guidelines recommend risk management plans to prevent drug product shortages.
-
Elevate Your Research With Comprehensive Tools And Expertise
2/18/2022
Streamline study activation and increase efficiencies with the partner trusted by tens of thousands of sites, institutions, academic medical centers, cancer centers, and health systems worldwide.
-
Overcome Challenges And Meet Timelines With FSP Site Support
9/11/2023
Offering a remedy to site-specific challenges, explore the ways PPD's Site Support Solutions are able to ensure that deadlines are met while accelerating the availability of new medications to patients.
-
Orphan Drug Designations
10/30/2023
Get unique insights into current expectations set by the U.S. Food and Drug Administration and the European Union, as well as distinctions between Orphan Drug Designation (ODD) criteria for the two entities.
-
ClinCard
4/10/2018
With more than 7 million payments, ClinCard is the industry-leading method for automated participant payments, delivering unmatched simplicity, security, and global reach.